Steven Cohen’s Opus Genetics IRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-18,922
Closed -$77.8K – 4692
2026
Q2
$77.8K Buy
+18,922
New +$88.3K ﹤0.01% 3735

Other funds holding IRD

Steven Cohen's IRD Position: Q3 2026 in Review

Steven Cohen sold out of Opus Genetics (IRD) in Q3 2026, closing a stake of 18,922 shares — an estimated $77.8K sold.

Steven Cohen first reported a position in IRD in Q2 2026 and held it in 1 quarter. The position peaked at $77.8K in Q2 2026. 114 funds tracked by Wall St. Rank hold IRD as of Q3 2026.

  • Steven Cohen reported no remaining Opus Genetics position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 18,922 Opus Genetics shares in Q3 2026, an estimated $77.8K.
  • Steven Cohen first reported a position in Opus Genetics in Q2 2026 and held it in 1 quarter.
  • Steven Cohen's Opus Genetics position peaked at $77.8K in Q2 2026.
  • 114 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.